About Us
BD officially established its representative office in China in 1994. Shanghai is the headquarters of BD China and in addition, there are 17 regional offices in different cities such as Beijing, Guangzhou and Chengdu. BD China with its 4,000 associates are committed to building a high-quality localized multinational company, with two manufacturing plants successively built in Suzhou and one plant under construction in Yixing. It has also established the BD Greater China R&D Center, as well as BD China Customer Service Center and Customer Experience Center serving more patients and healthcare workers in China, while helping advance the development of medical science.
BD Greater China R&D Center
Adhering to the guideline of In China, For China, BD China has developed a dual-center R&D strategy that situates the Innovation Design Center and Multifunctional Lab in Shanghai, and the Lab Engineering Center in Suzhou. Through detecting local customers' needs and discovering innovative opportunities, BD Greater China R&D Center develops customised products for Chinese customers and upgrades existing products. It also supports local registration and accelerates launch of new products, so as to support local customers and business teams.
Suzhou Plant I
- Built in 1995 covering 40,000m2 area
- 7,000m2 Class 100,000 clean rooms
- Three Intima II™ automatic production lines, the first Pegasus™ automatic production line of BD
- Awarded the Jiangsu Provincial Medical Instrument “Excellent and Integrity Company” title for 4 consecutive years
Suzhou Plant II
- In 2005, covering 43,800m2 area
- China 40 reagent went into local production
- Hypak™ prefilled syringe production line
- Honored as Advanced Company in Precursor Chemical Management by Suzhou Industrial Park
Yixing Plant (Under construction)
- Construction started in 2018 with 188 million USD investment in total; covering 32,407m2 area
- Owning world’s advanced production equipment, 8 automatic production lines will come into use for production
- Awarded the Advanced Company by government and Top 10 Companies with Industrial Stamina
Opportunities
As the second largest market among BD Worldwide, BD China has achieved outstanding growth in successive years with more than $1 billion in annualized revenue, which is inseparable from our continuous focus on and investment in local talent development and innovation efforts. Adhering to the guideline of “In China, for China”, BD China is committed to attracting, engaging, motivating and developing local talents with global mindset and innovative ideas. By promoting inclusion and diversity programs, BD China strives to create the best working environment that enable our diverse talent to be fully engaged, motivated and to fulfil their potentials. Join BD China to provide best class service to Chinese patients and healthcare workers, and together we can advance the world of health.
Awards
We are extremely proud to announce that BD China was awarded Top Employer 2018-2022 five years in a row, and Aon 2017 Best Employers of China. BD China was also awarded T+ Employer 2021-2022 two years in a row, to award BD China with pioneering influences in the healthcare industry. In addition, BD Suzhou Plant was certified as Greater Suzhou Best Employer 2019 and 2020.
In the Universum China Most Attractive Employers Social Campaign 2018, BD China was ranked TOP 10 among health/medical students. In addition, in recognition of BD China’s unremitting efforts on inclusion and diversity, and female career development, we won the silver medal of the Best Companies for Female Executives.
